11
total announcements
519353.BO · 15 min delayed
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has announced unaudited financial results for the quarter ended September 30, 2026, with revenue from operations at ₹ 2,678 and profit before tax at ₹ 3.32. The company has also provided a statement of unaudited standalone financial results and a statement of unaudited assets and liabilities.
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has announced unaudited financial results for the quarter ended September 30, 2026, with revenue from operations at ₹ 2,678 and profit before tax at ₹ 3.32.
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 02/11/2026 to consider and approve Un-Audited Financial Results for the Quarter ended on 30th September 2026.
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and updating the register of members.
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has closed its trading window for insiders from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Novyra Pharmachem Ltd
Novyra Pharmachem Ltd has informed the BSE that it has changed its official email ID, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The old email ID was bansisonstea@gmail.com and the new email ID is novyrapharmachemlimited@gmail.com. All future official correspondences, investor grievances, and communications may kindly be directed to the new email ID.
Bansisons Tea Industries Ltd
Bansisons Tea Industries Ltd has received approval to change its name to Novyra Pharmachem Limited, marking a key milestone in its expansion into the pharmaceutical, life sciences, and contract services sectors.
Bansisons Tea Industries Ltd
Bansisons Tea Industries Ltd, now known as Novyra Pharmachem Limited, has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a net loss of ₹1.99 crore for the quarter, compared to a net loss of ₹5.33 crore in the same period last year. Revenue from operations was ₹17.26 crore, down from ₹16.75 crore in the previous quarter.
Bansisons Tea Industries Ltd
Bansisons Tea Industries Ltd, now known as Novyra Pharmachem Limited, has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a net loss of ₹1.99 crore, with a total revenue from operations of ₹172.61 crore. The results are standalone and unaudited.
Bansisons Tea Industries Ltd
Bansisons Tea Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve Quarterly Results June 30, 2026.
Bansisons Tea Industries Ltd
Bansisons Tea Industries Ltd has changed its website address to www.novyrapharmachemltd.com, as per SEBI regulations.